An internal analysis conducted by Johnson & Johnson not long after it recalled a troubled hip implant estimated that the device would fail within five years in nearly 40% of patients.
Maker aware of 40% failure in hip implant
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content